UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Haemophilia

Nature reviews. Disease primers, 2021-06, Vol.7 (1), p.45-45, Article 45

2021

Volltextzugriff (PDF)

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study

Haematologica (Roma), 2021-01, Vol.106 (1), p.123-129

2021

Volltextzugriff (PDF)

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Blood, 2012-01, Vol.119 (2), p.612-618

2012

Volltextzugriff (PDF)

Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study

American journal of hematology, 2021-01, Vol.96 (1), p.51-59

2021

Volltextzugriff (PDF)

Surgery versus Physiotherapy for Stress Urinary Incontinence

The New England journal of medicine, 2013-09, Vol.369 (12), p.1124-1133

2013

Volltextzugriff (PDF)

Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels

Thrombosis and haemostasis, 2016, Vol.115 (5), p.913-920

2016

Volltextzugriff (PDF)

DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A

BMJ open, 2023-06, Vol.13 (6), p.e072363-e072363

2023

Volltextzugriff (PDF)

Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study

The Lancet. Haematology, 2017-02, Vol.4 (2), p.e75-e82

2017

Volltextzugriff (PDF)

MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia

Blood advances, 2020-01, Vol.4 (1), p.113-121

2020

Volltextzugriff (PDF)

Detecting low blood concentrations in joints using T1 and T2 mapping at 1.5, 3, and 7 T: an in vitro study

European radiology experimental, 2021-12, Vol.5 (1), p.51-51, Article 51

2021

Volltextzugriff (PDF)

Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study

Haematologica (Roma), 2017-09, Vol.102 (9), p.1486-1493

2017

Volltextzugriff (PDF)

Clinical outcomes in hemophilia: Towards development of a core set of standardized outcome measures for research

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.652-658

2020

Volltextzugriff (PDF)

Primary prophylaxis in haemophilia care: Guideline update 2016

Blood cells, molecules, & diseases, 2017-09, Vol.67, p.81-85

2017

Volltextzugriff (PDF)

Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12488-n/a, Article e12488

2021

Volltextzugriff (PDF)

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

Haematologica (Roma), 2015-03, Vol.100 (3), p.e84-e86

2015

Volltextzugriff (PDF)

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A

HemaSphere, 2021-05, Vol.5 (5), p.e557-n/a

2021

Volltextzugriff (PDF)

WITHDRAWN: Primary prophylaxis in haemophilia care: Guideline update 2016

Blood cells, molecules, & diseases, 2020-02, Vol.80, p.102172-102172, Article 102172

2020

Volltextzugriff (PDF)

Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A

HemaSphere, 2022-02, Vol.6 (2), p.e679-n/a

2022

Volltextzugriff (PDF)

Predicting Individual Changes in Terminal Half‐Life After Switching to Extended Half‐Life Concentrates in Patients With Severe Hemophilia

HemaSphere, 2022-04, Vol.6 (4), p.e694-n/a

2022

Volltextzugriff (PDF)

Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients

PloS one, 2009-08, Vol.4 (8), p.e6745-e6745

2009

Volltextzugriff (PDF)

Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed

Haematologica (Roma), 2016-03, Vol.101 (3), p.266-268

2016

Volltextzugriff (PDF)

Generic PROMIS item banks in adults with hemophilia for patient‐reported outcome assessment: Feasibility, measurement properties, and relevance

Research and practice in thrombosis and haemostasis, 2021-12, Vol.5 (8), p.e12621-e12621, Article e12621

2021

Volltextzugriff (PDF)

Targeting factor replacement therapy in severe hemophilia: which level is important?

Seminars in thrombosis and hemostasis, 2015-11, Vol.41 (8), p.860-863

2015

Volltextzugriff (PDF)

A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A

Haematologica (Roma), 2011-05, Vol.96 (5), p.738-743

2011

Volltextzugriff (PDF)

Impact of prophylaxis on health‐related quality of life of boys with hemophilia: An analysis of pooled data from 9 countries

Research and practice in thrombosis and haemostasis, 2019-07, Vol.3 (3), p.397-404

2019

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Englisch
(211)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Haemophilia

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study

Surgery versus Physiotherapy for Stress Urinary Incontinence

Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels

DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A

Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study

MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia

Detecting low blood concentrations in joints using T1 and T2 mapping at 1.5, 3, and 7 T: an in vitro study

Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study

Clinical outcomes in hemophilia: Towards development of a core set of standardized outcome measures for research

Primary prophylaxis in haemophilia care: Guideline update 2016

Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A

WITHDRAWN: Primary prophylaxis in haemophilia care: Guideline update 2016

Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A

Predicting Individual Changes in Terminal Half‐Life After Switching to Extended Half‐Life Concentrates in Patients With Severe Hemophilia

Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients

Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed

Generic PROMIS item banks in adults with hemophilia for patient‐reported outcome assessment: Feasibility, measurement properties, and relevance

Targeting factor replacement therapy in severe hemophilia: which level is important?

A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A

Impact of prophylaxis on health‐related quality of life of boys with hemophilia: An analysis of pooled data from 9 countries

Suchergebnisse filtern